.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Farmers Insurance
Teva
McKesson
Citi
Fuji
QuintilesIMS
Express Scripts
Baxter
Chinese Patent Office

Generated: November 22, 2017

DrugPatentWatch Database Preview

Patent Applications for EPINEPHRINE

« Back to Dashboard

US Patent Applications for EPINEPHRINE

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
► Subscribe► SubscribeCHRONIC RHEUMATOID ARTHRITIS THERAPY CONTAINING IL-6 ANTAGONIST AS EFFECTIVE COMPONENT2001-01-09Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622015-10-12
► Subscribe► SubscribeMulti-phase food & beverage2000-12-27Abandoned -- Failure to Respond to an Office Action2002-05-08
► Subscribe► SubscribeFATTY ACID-PHARMACEUTICAL AGENT CONJUGATES2000-12-05Patented Case2003-05-21
► Subscribe► SubscribePHOTOBLEACHING COMPOSITIONS COMPRISING MIXED METALLOCYANINES1999-07-23Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622006-08-02
► Subscribe► SubscribeEFFERVESCENCE POLYMERIC FILM DRUG DELIVERY SYSTEM1996-10-29Abandoned -- Failure to Respond to an Office Action2003-07-28
► Subscribe► SubscribeNUTRITIONALLY ACTIVE COMPOSITION FOR BODYBUILDING1998-11-25Abandoned -- Failure to Respond to an Office Action2001-10-22
► Subscribe► SubscribeMethods and formulations for treatment of premature ejaculation2001-02-26Abandoned -- Failure to Respond to an Office Action2003-12-11
► Subscribe► SubscribeDNA ENCODING GALANIN GALR3 RECEPTORS AND USES THEREOF1997-07-23Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622010-01-11
► Subscribe► SubscribePROCESS OF DELIVERING A POLYNUCLEOTIDE TO A CELL VIA THE VASCULAR SYSTEM1998-04-30Abandoned -- Failure to Respond to an Office Action2002-04-08
► Subscribe► SubscribePROSTATE DERIVED ETS FACTOR1998-07-31Abandoned -- Failure to Respond to an Office Action2004-06-25
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

WIPO Patent Applications for EPINEPHRINE

WIPO Patent Application Title Patent Filing Date
► Subscribe
► Subscribe
► Subscribe
► Subscribe
► Subscribe
► Subscribe
► Subscribe
► Subscribe
► Subscribe
► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Colorcon
Citi
Queensland Health
Cerilliant
Teva
QuintilesIMS
Argus Health
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot